For media inquires, please email press@juul.com.
August 23, 2023
Today, JLI is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a…
July 19, 2023
Juul Labs today announced the submission of the first Premarket Tobacco Product Application (PMTA) for the company’s next-generation vapor platform to the U.S. Food and Drug Administration (FDA).
June 30, 2023
Today Juul Labs announced that it has filed complaints against NJOY with the United States International Trade Commission (ITC or Commission) and the United…
April 17, 2023
Resolution of issues from the company’s past and its historical legal challenges has remained a critical priority to secure certainty for our future. While…
April 12, 2023
This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms…
April 10, 2023
This settlement with the West Virginia Attorney General represents yet another step in Juul Labs’ ongoing commitment to resolve issues from the company’s past….
March 17, 2023
In a new white paper entitled “The Real-World Impact of ENDS for Adult Smokers: Tobacco Harm Reduction Through Real-World Data and Evidence,” Juul Labs has reviewed and compiled the latest science and evidence demonstrating the positive real-world impact of ENDS products for adult smokers.
March 3, 2023
The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…
January 2, 2023
This settlement is a continuation of Juul Labs’ progress to resolve issues from the past. We applaud the Attorney General’s plan to deploy resources…
December 12, 2022
This settlement is a continuation of Juul Labs’ progress to resolve issues from the past. We applaud the Attorney General’s plan to deploy resources…